Efficacy and Safety of IPG11406 in Moderately to Severely Active Ulcerative Colitis (Phase 2)

You may not be if

• 1. Diagnosis of indeterminate colitis or Crohn's disease
• 2. History of bowel surgery for UC or likely requiring surgery during study
• 3. Ulcerative proctitis only (distal ≤15 cm)
• 4. History of colonic dysplasia or adenomatous polyps not completely removed
• 5. Active intestinal infection (including C. difficile) within 30 days
• 6. HBV, HCV, HIV, or untreated latent/active TB
• 7. Significant cardiovascular disease or uncontrolled hypertension
• 8. Clinically significant abnormal ECG or QTcF prolongation
• 9. Treatment with prohibited medications within specified windows
• 10. Abnormal laboratory values at screening
• 11. History of malignancy (except non-melanoma skin cancer or in situ cervical cancer)
• 12. Pregnancy, breastfeeding, or plan to become pregnant
• 13. Alcohol or drug abuse within 6 months
• 14. Prior participation in an IPG11406 study
• 15. Other conditions deemed inappropriate by the investigator